Anesthesia for the carcinoid syndrome.

Cushing’s syndrome associated with typical, peripheral pulmonary carcinoid tumor and N2 lymph node metastasis: case report

Background: The bronchopulmonary carcinoid tumor accounts for 1-2% of all adult malignancies of the lung and 20-30% of all carcinoid tumors. Cushing’s syndrome is the result of chronic exposure to increased concentration of exogenous or endo-genus cortisol hormone, and it is generally associated with central obesity, metabolic syndrome, and hypertension. Treatment is based on decreasing cortiso...

Total Intravenous Anesthesia (tiva) for Carcinoid Syndrome

There are three main areas of origin for carcinoid tumors: foregut carcinoid tumours start in the lungs, bronchi, or stomach; midgut carcinoid tumours start in the small intestine, appendix, or proximal large bowel; and hindgut carcinoid tumours start in the distal colon or rectum3. The appendix is the most common site of carcinoid tumors, followed by the rectum, ileum, lungs, bronchi, and stom...

Carcinoid tumor and intravenous octreotide infusion during labor and delivery.

There are limited numbers of reports concerning the management of pregnancy complicated by carcinoid tumors. Octreotide, the synthetic analogue of somatostatin, has been found to be beneficial in preventing the perioperative exacerbation of carcinoid syndrome. We present a case of the successful use of neuraxial analgesia/anesthesia for labor and vaginal delivery in a symptomatic parturient aff...

Carcinoid syndrome and perioperative anesthetic considerations.

Carcinoid tumors are uncommon, slow-growing neoplasms. These tumors are capable of secreting numerous bioactive substances, which results in significant potential challenges in the management of patients afflicted with carcinoid syndrome. Over the past two decades, both surgical and medical therapeutic options have broadened, resulting in improved outcomes. The pathophysiology, clinical signs a...

Anesthesia and the malignant carcinoid syndrome.